Gsa Capital Partners LLP Landec Corp \Ca\ Transaction History

Gsa Capital Partners LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.0 - $9.95 $0 - $45,332	4,556 Added 29.57%	19,966 $129,000
Q3 2022 Nov 14, 2022	BUY	$8.57 - $11.57 $132,063 - $178,293	15,410 New	15,410 $137,000
Q4 2021 Feb 14, 2022	SELL	$7.95 - $11.24 $319,216 - $451,319	-40,153 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.22 - $12.44 $370,210 - $499,503	40,153 New	40,153 $370,000
Q1 2021 May 10, 2021	SELL	$10.44 - $12.22 $246,446 - $288,465	-23,606 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$9.3 - $11.77 $226,296 - $286,399	-24,333 Reduced 50.76%	23,606 $256,000
Q3 2020 Nov 06, 2020	BUY	$7.59 - $10.8 $253,012 - $360,018	33,335 Added 228.26%	47,939 $466,000
Q2 2020 Aug 11, 2020	BUY	$7.96 - $11.54 $116,247 - $168,530	14,604 New	14,604 $116,000
Q3 2019 Nov 12, 2019	SELL	$9.66 - $12.36 $126,826 - $162,274	-13,129 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$9.32 - $12.98 $122,362 - $170,414	13,129 New	13,129 $123,000

20.3M

79.7K

31.6K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.